Brief: Vor Biopharma Terminates CFO Han Choi
08/05/2025 16:09
May 8 (Reuters) - Vor Biopharma Inc VOR.O: VOR BIOPHARMA INC - WIND DOWN COSTS ESTIMATED AT $19.3 MILLION - SEC FILING VOR BIOPHARMA INC - TERMINATES CFO HAN CHOI AND CSO TIRTHA CHAKRABORTY - SEC FILING ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vor Biopharma
See all newsBrief: Telitacicept Demonstrates Durable Preservation Of Kidney Function Through Two Years In Phase 3 Teligan Trial In Iga Nephropathy
Vor Bio says its experimental drug slowed loss of kidney function in late-stage study
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
U.S. STOCKS ON THE MOVE-Snowflake, Cboe, Oracle
US STOCKS ON THE MOVE-Veracyte, Staar Surgical, Corning